Literature DB >> 4598016

Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.

H Kirchner, T M Chused, R B Herberman, H T Holden, D H Lavrin.   

Abstract

Spleens from Moloney sarcoma virus (MSV) tumor-bearing C57BL/6N mice contained four times the normal number of mononuclear cells and displayed a markedly elevated "spontaneous" (mitogen-independent) DNA synthesis on a per cell basis. The number of macrophages were increased three-fold while there was a slight reduction in the percentage of T lymphocytes. The phytohemagglutinin (PHA) response on a per cell basis of spleens from tumor-bearing mice was decreased about 90% when compared with normal control mice. The primary in vitro immune response to sheep red blood cells was also suppressed to levels of less than 10% of normals. The PHA response could be restored by purification of MSV spleen cells by rayon adherence columns and by removal of phagocytic cells by an iron/magnet technique. The activity of suppressor cells in MSV spleens was demonstrated in mixtures with syngeneic normal spleen cells where a marked impairment of the PHA response was observed. Spleen cells from tumor-free nude mice and normal spleen cells treated by anti-theta serum plus guinea pig complement (C'), both totally unreactive to PHA, had no such effect. The inhibitor cell in MSV spleens was shown to be insensitive to inactivation by anti-theta plus C', but could be removed by the adherence columns and the iron/magnet technique. These data suggest that this suppressor cell is a cell of the monocyte/macrophage series. Suggestive evidence was also presented that the suppressor cells belong to a proliferating population in MSV spleens. Similar suppressor cells have been previously demonstrated in spleens of mice during a variety of immune responses. Our data show, that a tumor, although stimulating the immune system, nevertheless may be suppressive on certain immune functions through the activation of suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4598016      PMCID: PMC2139691          DOI: 10.1084/jem.139.6.1473

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Inhibition of phytohemagglutinin- and alloantigen-induced lymphocyte stimulation by Rauscher leukemia virus.

Authors:  P Häyry; D Rago; V Defendi
Journal:  J Natl Cancer Inst       Date:  1970-06       Impact factor: 13.506

2.  Enhanced antibody response of mice to polyinosinic-polycytidylic acid by antithymocyte serum and its age-dependent loss in NZB-W mice.

Authors:  T M Chused; A D Steinberg; L M Parker
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

Review 3.  Possibilities and problems of immunologic intervention in cancer.

Authors:  R T Smith
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

4.  Thymic dependency of tumor-induced immunodepression.

Authors:  G F Rowland; A J Edwards; M R Sumner; C M Hurd
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

5.  Suppressor T cells.

Authors:  R K Gershon; P Cohen; R Hencin; S A Liebhaber
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

Review 6.  Experimental studies in tumor imminology.

Authors:  G Klein
Journal:  Fed Proc       Date:  1969 Nov-Dec

7.  Immune capacity and response to antigenic tumors.

Authors:  R J Risdall; J C Aust; C F McKhann
Journal:  Cancer Res       Date:  1973-09       Impact factor: 12.701

8.  Amplifying and suppressive effect of thymus cells.

Authors:  W Droege
Journal:  Nature       Date:  1971-12-31       Impact factor: 49.962

9.  Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens.

Authors:  G Janossy; M F Greaves
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

10.  Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.

Authors:  J L McCoy; A Fefer; J P Glynn
Journal:  Cancer Res       Date:  1967-10       Impact factor: 12.701

View more
  62 in total

1.  The potentiating, mitogenic and inhibitory effects on lymphocytes in vitro, of macrophages in the lymph nodes of mice 'overloaded' with mycobacterial products.

Authors:  G A Rook
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

2.  Cell mediated immunity in experimental rubella infections.

Authors:  R Cappel
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

3.  Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A.

Authors:  F Esquivel; C E Taylor; P J Baker
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

4.  Concanavalin A-activated suppressor cells in normal human peripheral blood lymphocytes.

Authors:  C Hubert; G Delespesse; A Govaerts
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

5.  T lymphocyte function as the principal target of lymphocytic choriomeningitis virus-induced immunosuppression.

Authors:  K Bro-Jorgensen; F Güttler; P N Jorgensen; M Volkert
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

Review 6.  Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.

Authors:  H Fujiwara; T Hamaoka
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

7.  Radiation-induced augmentation of the response of A/J mice to SaI tumor cells.

Authors:  R E Anderson; S Tokuda; W L Williams; N L Warner
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

8.  Influence of malaria infection on the elaboration of soluble mediators by adherent mononuclear cells.

Authors:  D J Wyler; J J Oppenheim; L C Koontz
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

9.  Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.

Authors:  R N Germain; R M Williams; B Benacerraf
Journal:  Am J Pathol       Date:  1976-12       Impact factor: 4.307

10.  Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.

Authors:  P Katz; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.